{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:04:47Z","timestamp":1790809487463,"version":"4.1.0"},"reference-count":59,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"INSERM U955 (Cr\u00e9teil)"},{"name":"AP-HP Saint-Louis CRMR MATHEC (center of reference for rare autoimmune diseases of Ile de France)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Systemic Sclerosis (SSc) is a chronic autoimmune disease with high morbidity and mortality. Autologous Hematopoietic Stem Cell Transplantation (AHSCT) is the best therapeutic option for rapidly progressive SSc, allowing increased survival with regression of skin and lung fibrosis. The immune determinants of the clinical response after AHSCT have yet to be well characterized. In particular, the pivotal role of the Human Leukocyte Antigen (HLA) system is not well understood, including the role of non-classical immuno-modulatory HLA-E and HLA-G molecules in developing tolerance and the role of Natural Killer cells (NK) in the immunomodulation processes. We retrospectively tested whether the genetic and\/or circulating expression of the non-classical HLA-E and HLA-G loci, as well as the imputed classical HLA determinants of HLA-E expression, influence the observed clinical response to AHSCT at 12- and 24-month follow-up. In a phenotypically well-defined sample of 46 SSc patients classified as clinical responders or non-responders, we performed HLA genotyping using next-generation sequencing and circulating levels of HLA-G and quantified HLA-E soluble isoforms by ELISA. The -21HLA-B leader peptide dimorphism and the differential expression level of HLA-A and HLA-C alleles were imputed. We observed a strong trend towards better clinical response in HLA-E*01:03 or HLA-G 14bp Del allele carriers, which are known to be associated with high expression of the corresponding molecules. At 12-month post-AHSCT follow-up, higher circulating levels of soluble HLA-E were associated with higher values of modified Rodnan Skin Score (mRSS) (p = 0.0275), a proxy of disease severity. In the non-responder group, the majority of patients carried a double dose of the HLA-B Threonine leader peptide, suggesting a non-efficient inhibitory effect of the HLA-E molecules. We did not find any correlation between the soluble HLA-G levels and the observed clinical response after AHSCT. High imputed expression levels of HLA-C alleles, reflecting more efficient NK cell inhibition, correlated with low values of the mRSS 3 months after AHSCT (p = 0.0087). This first pilot analysis of HLA-E and HLA-G immuno-modulatory molecules suggests that efficient inhibition of NK cells contributes to clinical response after AHSCT for SSc. Further studies are warranted in larger patient cohorts to confirm our results.<\/jats:p>","DOI":"10.3390\/ijms23137223","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T20:47:56Z","timestamp":1656535676000},"page":"7223","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Non-Classical HLA Determinants of the Clinical Response after Autologous Stem Cell Transplantation for Systemic Sclerosis"],"prefix":"10.3390","volume":"23","author":[{"given":"Wahid","family":"Boukouaci","sequence":"first","affiliation":[{"name":"Translational Neuropsychiatry Laboratory, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (IN-SERM, U955), Institut Mondor de Recherche Biom\u00e9dicale, Universit\u00e9 Paris Est Creteil, F-94010 Creteil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0821-3882","authenticated-orcid":false,"given":"Pauline","family":"Lansiaux","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de M\u00e9decine Interne (UF 04): CRMR MATHEC, Maladies Auto-Immunes et Th\u00e9rapie Cellulaire, Centre de R\u00e9f\u00e9rence des Maladies Auto-Immunes Syst\u00e9miques Rares D\u2019ILE-de-France, H\u00f4pital St-Louis, Assistance-Publique H\u00f4pitaux de Paris, F-75010 Paris, France"},{"name":"URP-3518: Recherche Clinique en H\u00e9matologie, Immunologie et Transplantation, Institut de Recherche Saint-Louis, Universit\u00e9 Paris Cit\u00e9, F-75010 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie C.","family":"Lambert","sequence":"additional","affiliation":[{"name":"UMRs 1097 Arthrites Autoimmunes, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), Aix Marseille University, F-13288 Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Picard","sequence":"additional","affiliation":[{"name":"UMR7268 ADES (Anthropologie Bio-Culturelle, Droit, Ethique et Sant\u00e9), Universit\u00e9 Aix-Marseille, Etablissement Fran\u00e7ais du Sang, Centre National de la Recherche Scientifique (CNRS), F-13005 Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8217-5039","authenticated-orcid":false,"given":"Emmanuel","family":"Clave","sequence":"additional","affiliation":[{"name":"EMiLy (Ecotaxie, Microenvironnement et Developpement Lymphocytaire), Inserm U1160, Institut de Recherche Saint Louis, Universit\u00e9 de Paris, F-75010 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Cras","sequence":"additional","affiliation":[{"name":"Cell Therapy Unit, Saint Louis Hospital, Assistance-Publique H\u00f4pitaux de Paris, F-75010 Paris, France"},{"name":"UMR1140, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), Universit\u00e9 de Paris, F-75006 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zora","family":"Marjanovic","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hopital Saint Antoine, F-75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Farge","sequence":"additional","affiliation":[{"name":"URP-3518: Recherche Clinique en H\u00e9matologie, Immunologie et Transplantation, Institut de Recherche Saint-Louis, Universit\u00e9 Paris Cit\u00e9, F-75010 Paris, France"},{"name":"UMRs 1097 Arthrites Autoimmunes, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), Aix Marseille University, F-13288 Marseille, France"},{"name":"Department of Medicine, McGill University, Montreal, QC H3A 1A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3992-9565","authenticated-orcid":false,"given":"Ryad","family":"Tamouza","sequence":"additional","affiliation":[{"name":"Translational Neuropsychiatry Laboratory, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (IN-SERM, U955), Institut Mondor de Recherche Biom\u00e9dicale, Universit\u00e9 Paris Est Creteil, F-94010 Creteil, France"},{"name":"Fondation FondaMental, D\u00e9partement M\u00e9dico-Universitaire de Psychiatrie et d\u2019Addictologie (DMU IMPACT), F\u00e9d\u00e9ration Hospitalo-Universitaire de M\u00e9decine de Pr\u00e9cision en Psychiatrie (FHU ADAPT), Assistance-Publique H\u00f4pitaux de Paris, F-94010 Creteil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/ITT.S82037","article-title":"Current perspectives on the immunopathogenesis of systemic sclerosis","volume":"5","author":"Fuschiotti","year":"2016","journal-title":"Immunotargets Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/rheumatology\/kel189","article-title":"Impact of pain in health related quality of life of patients with systemic sclerosis","volume":"45","author":"Georges","year":"2006","journal-title":"Rheumatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/art.24676","article-title":"Health-related quality of life in systemic sclerosis: A systematic review","volume":"61","author":"Hudson","year":"2009","journal-title":"Arthritis Rheumatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: Systematic review and meta-analysis","volume":"44","author":"Royo","year":"2014","journal-title":"Semin. Arthritis Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.40027","article-title":"Early Mortality in a Multinational Systemic Sclerosis Inception Cohort","volume":"69","author":"Hao","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/ard.2010.144360","article-title":"Clinical prediction of 5-year survival in systemic sclerosis: Validation of a simple prognostic model in EUSTAR centres","volume":"70","author":"Fransen","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.7326\/0003-4819-97-5-652","article-title":"D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): A retrospective analysis","volume":"97","author":"Steen","year":"1982","journal-title":"Ann. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jacc.2017.11.061","article-title":"Left Ventricle Replacement Fibrosis Detected by CMR Associated With Cardiovascular Events in Systemic Sclerosis Patients","volume":"71","author":"Mousseaux","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/art.40130","article-title":"Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis","volume":"69","author":"Goh","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/art.1790040106","article-title":"The use of the health assessment questionnaire (HAQ) to determine physical disability in systemic sclerosis","volume":"4","author":"Poole","year":"1991","journal-title":"Arthritis Care Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: A study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): An open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs. intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: A randomized clinical trial","volume":"311","author":"Farge","year":"2014","journal-title":"JAMA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.bbmt.2018.06.025","article-title":"Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation","volume":"24","author":"Sullivan","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Fransen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bbmt.2020.03.002","article-title":"Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy","volume":"26","author":"Kanate","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41409-019-0516-2","article-title":"Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: Current practice in Europe, 2019","volume":"54","author":"Duarte","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1046\/j.1365-2141.2002.03895.x","article-title":"Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: Early results from a French multicentre phase I-II study","volume":"119","author":"Farge","year":"2002","journal-title":"Br. J. Haematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(12)62114-X","article-title":"Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: A retrospective analysis","volume":"381","author":"Burt","year":"2013","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13045-016-0388-5","article-title":"Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients","volume":"10","author":"Farge","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/bloodadvances.2017011072","article-title":"Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients","volume":"2","author":"Arruda","year":"2018","journal-title":"Blood Adv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-genom-091212-153455","article-title":"Major Histocompatibility Complex Genomics and Human Disease","volume":"14","author":"Trowsdale","year":"2013","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0198-8859(99)00161-5","article-title":"Paired inhibitory and triggering NK cell receptors for HLA class I molecules","volume":"61","author":"Llano","year":"2000","journal-title":"Hum. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.it.2017.01.009","article-title":"HLA-G: At the Interface of Maternal\u2013Fetal Tolerance","volume":"38","author":"Ferreira","year":"2017","journal-title":"Trends Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1074\/jbc.M208268200","article-title":"HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities","volume":"278","author":"Strong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.ajhg.2016.09.023","article-title":"HLA-C Level Is Regulated by a Polymorphic Oct1 Binding Site in the HLA-C Promoter Region","volume":"99","author":"Vince","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aam8825","article-title":"Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells","volume":"359","author":"Ramsuran","year":"2018","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1399-0039.2008.01107.x","article-title":"The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma","volume":"72","author":"Chen","year":"2008","journal-title":"Tissue Antigens"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0952-7915(99)80048-X","article-title":"Natural killer cell activation and inhibition by receptors for MHC class I","volume":"11","year":"1999","journal-title":"Curr. Opin. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.4049\/jimmunol.169.11.6102","article-title":"NK cell CD94\/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes","volume":"169","author":"Borrego","year":"2002","journal-title":"J. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4326495","DOI":"10.1155\/2016\/4326495","article-title":"Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases","volume":"2016","author":"Morandi","year":"2016","journal-title":"J. Immunol. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3389\/fimmu.2020.01178","article-title":"HLA-G Genotype\/Expression\/Disease Association Studies: Success, Hurdles, and Perspectives","volume":"11","author":"Amodio","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/cei.12633","article-title":"Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis","volume":"181","author":"Favoino","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.humimm.2019.12.004","article-title":"Expression of membrane-bound human leucocyte antigen-G in systemic sclerosis and systemic lupus erythematosus","volume":"81","author":"Negrini","year":"2020","journal-title":"Hum. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3389\/fimmu.2019.01179","article-title":"Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation","volume":"10","author":"Pende","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00251-020-01161-x","article-title":"Tuning of human NK cells by endogenous HLA-C expression","volume":"72","author":"Krepel","year":"2020","journal-title":"Immunogenetics"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S2352-3026(19)30208-X","article-title":"Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: A retrospective cohort study","volume":"7","author":"Petersdorf","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Petersdorf, E.W., Gooley, T., Volt, F., Kenzey, C., Madrigal, A., McKallor, C., Querol, S., Rafii, H., Rocha, V., and Tamouza, R. (2020). Use of the HLA-B leader to optimize cord-blood transplantation. Haematologica.","DOI":"10.3324\/haematol.2020.264424"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/01.tp.0000244598.92049.dd","article-title":"Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation","volume":"82","author":"Tamouza","year":"2006","journal-title":"Transplantation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fimmu.2011.00074","article-title":"Association of HLA-G Low Expressor Genotype with Severe Acute Graft-Versus-Host Disease after Sibling Bone Marrow Transplantation","volume":"2","author":"Boukouaci","year":"2011","journal-title":"Front. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.3389\/fimmu.2019.03027","article-title":"Decreased Soluble Human Leukocyte Antigen E Levels in Patients After Allogeneic Hematopoietic Stem Cell Transplantation Are Associated with Severe Acute and Extended Chronic Graft-versus-Host Disease and Inferior Overall Survival","volume":"10","author":"Kordelas","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"956878","DOI":"10.1155\/2013\/956878","article-title":"Plasma levels of soluble HLA-E and HLA-F at diagnosis may predict overall survival of neuroblastoma patients","volume":"2013","author":"Morandi","year":"2013","journal-title":"BioMed Res. Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.4049\/jimmunol.177.5.3100","article-title":"Expression and release of HLA-E by melanoma cells and melanocytes: Potential impact on the response of cytotoxic effector cells","volume":"177","author":"Corvaisier","year":"2006","journal-title":"J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s40425-019-0761-3","article-title":"Monalizumab: Inhibiting the novel immune checkpoint NKG2A","volume":"7","author":"Horowitz","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G: An Immune Checkpoint Molecule","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/cei.13134","article-title":"Evaluation of membrane-bound and soluble forms of human leucocyte antigen-G in systemic sclerosis","volume":"193","author":"Contini","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3389\/fimmu.2020.01613","article-title":"HLA-G Expressing Immune Cells in Immune Mediated Diseases","volume":"11","author":"Contini","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: An American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"Khanna","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/bmt.2011.185","article-title":"Haematopoietic SCT in severe autoimmune diseases: Updated guidelines of the European Group for Blood and Marrow Transplantation","volume":"47","author":"Snowden","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/j.bulcan.2017.06.019","article-title":"Indications et suivi des autogreffes de cellules souches h\u00e9matopo\u00ef\u00e9tiques dans les maladies auto-immunes et auto-inflammatoires: Recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC)","volume":"104","author":"Pugnet","year":"2017","journal-title":"Bull. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/bmt.2014.251","article-title":"SCT for severe autoimmune diseases: Consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking","volume":"50","author":"Alexander","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.bulcan.2021.03.020","article-title":"Autologous hematopoietic cells for severe autoimmune diseases: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) for immune monitoring and biobanking","volume":"108","author":"Lansiaux","year":"2021","journal-title":"Bull. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1158\/0008-5472.CAN-04-0937","article-title":"Immunogenicity of Constitutively Active V599EBRaf","volume":"64","author":"Andersen","year":"2004","journal-title":"Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.humimm.2012.10.027","article-title":"HLA-G haplotype structure shows good conservation between different populations and good correlation with high, normal and low soluble HLA-G expression","volume":"74","author":"Agnel","year":"2013","journal-title":"Hum. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/ajt.13305","article-title":"HLA-G*01:04\u223cUTR3 Recipient Correlates With Lower Survival and Higher Frequency of Chronic Rejection After Lung Transplantation","volume":"15","author":"Carlini","year":"2015","journal-title":"Am. J. Transplant."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.humimm.2005.05.003","article-title":"Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004","volume":"66","author":"Rebmann","year":"2005","journal-title":"Hum. Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/13\/7223\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:40:17Z","timestamp":1760139617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/13\/7223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":59,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["ijms23137223"],"URL":"https:\/\/doi.org\/10.3390\/ijms23137223","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]}}}